Could a Blood Marker of T-Cell Exhaustion be Inflammatory Bowel Disease's New Crystal Ball?
- PMID: 31954112
- PMCID: PMC7062560
- DOI: 10.1053/j.gastro.2020.01.021
Could a Blood Marker of T-Cell Exhaustion be Inflammatory Bowel Disease's New Crystal Ball?
Comment on
-
A blood-based prognostic biomarker in IBD.Gut. 2019 Aug;68(8):1386-1395. doi: 10.1136/gutjnl-2019-318343. Epub 2019 Apr 27. Gut. 2019. PMID: 31030191 Free PMC article.
References
-
- Ng SC, et al., Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet, 2018. 390(10114): p. 2769–2778. - PubMed
-
- Kaplan GG, The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol, 2015. 12(12): p. 720–7. - PubMed
-
- Rogler G and Biedermann L, Clinical Utility of Biomarkers in IBD. Curr Gastroenterol Rep, 2015. 17(7): p. 26. - PubMed
-
- Yamamoto T, et al., Fecal calprotectin and lactoferrin as predictors of relapse in patients with quiescent ulcerative colitis during maintenance therapy. Int J Colorectal Dis, 2014. 29(4): p. 485–91. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources